EASL Clinical Practice Guidelines

Conflict of interest

Laurent Castera:

  • Grant and research support: none
  • Advisory Boards: none
  • Speaking and teaching: AbbVie, Biopredictive, Bristol-Myers Squibb, Echosens, Gilead, Merck and Janssen


Henry Lik Yuen Chan:

  • Grant and research support: unrestricted grant from Roche
  • Advisory Boards: Abbvie, Bristol Myers Squibb, Gilead, Janssen, Merck, Novartis, Roche
  • Speaking and teaching: Abbvie, Bristol Myers Squibb, Echosens, Gilead, Glaxo-Smith-Kline, Merck, Novartis, Roche


Marco Arrese:

  • Grant and research support: Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT 1110455) and the Comisión Nacional de Investigación Científica y Tecnológica (grant PFB 12/2007, Basal Centre for Excellence in Science and Technology) from the government of Chile
  • Advisory Boards: none
  • Speaking and teaching: none


Nezam Afdhal:

  • Grant and research support: Merck, Vertex, Gilead, AbbVie, BMS
  • Advisory Boards: Merck, Gilead, Echosens, Glaxo Smith Kline, Ligand, Springbank, Kadmon, Jannsen, AbbVie, Achillion, Sandhill Scientific
  • Speaking and teaching: none


Pierre Bedossa:

  • Grant and research support: none
  • Advisory Boards: none
  • Speaking and teaching: Gilead, Genfit, Echosens, Intercep


Mireen Friedrich-Rust:

  • Grant and research support: Echosens, Siemens Medical, Supersonic Imagine
  • Advisory Boards: none
  • Speaking and teaching: Echosens, Siemens Medical


Kwang-Hyub Han:

  • Grant and research support: Medigen co., Eisai co. and KOWA co.
  • Advisory Boards: Eisai co. and KOWA co.
  • Speaking and teaching: nothing to disclose



Massimo Pinzani:

  • Grant and research support: none
  • Advisory Boards: Intercept, Abbvie, USB Cell Tech, Silence Therapeutics
  • Speaking and teaching: Gilead, BMS, Jansen, Norgine, Gore, MSD, Echosens